FDA approves two Vuse e-cigarette models

May.13.2022
FDA approves PMTA review for Vuse brand e-cigarettes - Vibe and Ciro, but not for the popular Alto product.

The U.S. Food and Drug Administration (FDA) has approved PMTA applications for two Vuse brand e-cigarettes, Vibe and Ciro. However, Vuse's best-selling product, Alto, is still undergoing PMTA review.

 

Two models of electronic cigarettes, each with two corresponding battery types, as well as accompanying closed tobacco-flavored pods (Vibe with 3% nicotine, Ciro with 1.5% nicotine), have also been approved.

 

However, Vuse Vibe and Vuse Ciro flavors other than tobacco have not passed PMTA review, meaning they cannot be legally sold.

 

The Vuse Vibe and Ciro devices are outdated models with low sales in the market. In contrast, the NJOY Ace approved through PMTA in April is a more popular product in the market.

 

Earlier, two Vuse products received PMTA approval: the Vuse Solo in October 2021 and the Vuse Logic in March 2022.

 

Source: FDA

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Research shows that nearly 40% of college students in the UAE use e-cigarettes, ranking first among Arab countries
Research shows that nearly 40% of college students in the UAE use e-cigarettes, ranking first among Arab countries
UAE university students' e-cigarette usage rate is highest among 5 Arab countries, citing accessibility, flavors, marketing, and income.
Sep.24 by 2FIRSTS.ai
InterTabac 2025 Insights|Nicotine Pouches Reach 70mg/g, Cotton-Pad Oral Products Also on Display
InterTabac 2025 Insights|Nicotine Pouches Reach 70mg/g, Cotton-Pad Oral Products Also on Display
GARANT Nicotine Pouches at Inter Tabac 2025 At the Inter Tabac 2025 exhibition, GARANT showcased its new nicotine pouch line. According to on-site observations by 2Firsts, the brand unveiled nicotine pouches with concentrations up to 70mg/g, as well as mini pouches with a capacity of 35 per tin. The products featured a unique, square, cotton-pad shape.
Sep.23 by 2FIRSTS.ai
PMI: Illicit Trade in Smoke-Free Products in the Philippines Could Reach 80%; Major Gap Between China’s Exports and PH Imports
PMI: Illicit Trade in Smoke-Free Products in the Philippines Could Reach 80%; Major Gap Between China’s Exports and PH Imports
At the Financial Times Illicit Trade Forum in Taguig City, Rodney Van Dooren, Regional Illicit Trade Expert at Philip Morris International (PMI), said illicit consumption of smoke-free products (including e-cigarettes) in the Philippines “could be as high as 80%.” He cited a large discrepancy between China’s e-cigarette export figures and the Philippines’ official import data, suggesting significant volumes are entering outside formal channels.
Sep.22 by 2FIRSTS.ai
2Firsts Monitor | FOGER website flags customs & tariff delays; some products out of stock
2Firsts Monitor | FOGER website flags customs & tariff delays; some products out of stock
2Firsts observed on FOGER’s online retail site “FOGER VAPES” that the platform indicates restocking delays due to customs and tariff factors. Several items show limited availability or “sold out” status, with a restock alert feature offered. A previous article on the site also referenced potential tariff changes that may affect pricing.
Nov.05
KT&G Q3 Net Profit Up 73%; Overseas NGP Revenue Nearly Doubles, Nicotine Pouch Expansion Set to Launch Globally
KT&G Q3 Net Profit Up 73%; Overseas NGP Revenue Nearly Doubles, Nicotine Pouch Expansion Set to Launch Globally
KT&G reported its Q3 2025 financial results, posting revenue of KRW 1.83 trillion (≈USD 1.31 billion) and a 73.4% year-over-year surge in net profit—marking the company’s highest operating profit in five years. The Next Generation Product (NGP) segment performed strongly, generating KRW 279.1 billion (≈USD 199 million) in revenue, with overseas NGP sales more than doubling year-over-year.
Nov.06
Russia’s Health Ministry backs full ban on vapes and nalivaykas
Russia’s Health Ministry backs full ban on vapes and nalivaykas
Russia’s Ministry of Health (Minzdrav) has expressed support for a full ban on vapes and “nalivayka” alcohol outlets, calling it an effective measure to curb harmful habits and improve public health.
Oct.17 by 2FIRSTS.ai